Candida dubliniensis candidemia in Australia.
作者信息
Marriott D, Laxton M, Harkness J
出版信息
Emerg Infect Dis. 2001 May-Jun;7(3):479. doi: 10.3201/eid0703.010326.
Abstract
摘要
相似文献
1
Candida dubliniensis candidemia in Australia.
Emerg Infect Dis. 2001 May-Jun;7(3):479. doi: 10.3201/eid0703.010326.
2
Candidemia in patients with ventricular assist devices.
Clin Infect Dis. 2007 Jan 15;44(2):e9-12. doi: 10.1086/509640. Epub 2006 Dec 14.
3
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Bone Marrow Transplant. 1994 Mar;13(3):333-4.
4
Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
Haematologica. 2006 May;91(5):717-8.
5
[Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Rev Clin Esp. 1997 Dec;197(12):799-803.
6
Candida guilliermondii fungemia. To treat or not to treat.
Saudi Med J. 2004 Jan;25(1):115.
7
Risk factors for breakthrough candidemia.
Eur J Clin Microbiol Infect Dis. 2002 Mar;21(3):209-11. doi: 10.1007/s10096-002-0697-1. Epub 2002 Mar 19.
8
[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Rev Pneumol Clin. 2000 Feb;56(1):37-40.
9
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Arch Intern Med. 1995;155(22):2429-35.
10
Prevalence of Candida dubliniensis fungemia at a large teaching hospital.
Clin Infect Dis. 2005 Oct 1;41(7):1064-7. doi: 10.1086/432943. Epub 2005 Aug 30.
引用本文的文献
1
Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.
PLoS One. 2012;7(3):e32952. doi: 10.1371/journal.pone.0032952. Epub 2012 Mar 2.
2
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.
Antimicrob Agents Chemother. 2009 Dec;53(12):5297-9. doi: 10.1128/AAC.00980-09. Epub 2009 Sep 28.
3
Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana.
J Clin Microbiol. 2009 Jan;47(1):212-4. doi: 10.1128/JCM.01540-08. Epub 2008 Nov 5.
4
Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.
Emerg Infect Dis. 2008 Feb;14(2):327-9. doi: 10.3201/eid1402.070985.
5
Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.
J Clin Microbiol. 2008 Feb;46(2):652-64. doi: 10.1128/JCM.01574-07. Epub 2007 Dec 5.
6
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
J Clin Microbiol. 2004 Oct;42(10):4419-31. doi: 10.1128/JCM.42.10.4419-4431.2004.
7
Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):470-4. doi: 10.1007/s10096-003-0973-8. Epub 2003 Jul 23.
8
Candida dubliniensis infection, Singapore.
Emerg Infect Dis. 2002 Apr;8(4):445-6. doi: 10.3201/eid0804.010423.
9
Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.
J Clin Microbiol. 2002 Feb;40(2):556-74. doi: 10.1128/JCM.40.2.556-574.2002.
10
Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections.
J Clin Microbiol. 2001 Aug;39(8):2999-3001. doi: 10.1128/JCM.39.8.2999-3001.2001.
Zotero 插件